Amazon is diving deeper into the healthcare business as it launches its new unlimited prescription medication service for just $5 per month. The e-commerce firm has named the service RxPass, and it is exclusively offered to Prime members.
Subscribers of Amazon Pharmacy’s RxPass will be able to enjoy free delivery of medicines even if they order many times. The healthcare subscription service was launched on Tuesday this week and is now available in most states in the U.S.
Moreover, Prime members can also save on medicines since special discounts are also applied on top of the free delivery to homes. This service only shows that the company is slowly but continuously expanding its footprint in the healthcare market.
As per Fox Business, the $5 flat monthly fee covers various medicines, including antibiotic amoxicillin, naproxen anti-inflammatory drug, and sildenafil which is typically used for the treatment of erectile dysfunction. This is commonly known as Viagra and is also said to have the ability to treat some types of high blood pressure.
Even with the low subscription fee for RxPass, customers can fill as many prescriptions as they need. As long as the medicines are on the list, and Amazon said it has 50 generic medications. Some of the generic drugs are said to cost only $1 for a 30-day supply already. For other discounts, they can get up to 80% off on generic and 40% off on brand-name medicines; thus, the subscription is beneficial.
“Prime members already get fast, free delivery on prescription medications, and RxPass is one more way to save with Amazon Pharmacy. Any customer who pays more than $10 a month for their eligible medications will see their prescription costs drop by 50% or more, plus they save time by skipping a trip to the pharmacy,” Amazon Pharmacy’s vice president, John Love, said in a press release. “We are excited to offer our customers surprisingly simple, low pricing on the eligible medications they need each month.”
Photo by: Bastian Riccardi/Pixabay


Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
India Services Sector Rebounds in January as New Business Gains Momentum: HSBC PMI Shows Growth
US-India Trade Bombshell: Tariffs Slashed to 18% — Rupee Soars, Sensex Explodes
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
China Services PMI Hits Three-Month High as New Orders and Hiring Improve
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
China and Uruguay Strengthen Strategic Partnership Amid Shifting Global Order
Denso Cuts Profit Forecast Amid U.S. Tariffs and Rising Costs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Trump Extends AGOA Trade Program for Africa Through 2026, Supporting Jobs and U.S.-Africa Trade
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



